Amphastar Pharmaceuticals (AMPH) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Here Are the Major Earnings After the Close Today
Seeking AlphaFeb 27 10:00 ET
Earnings Scheduled For February 27, 2025
BenzingaFeb 27 03:32 ET
Amphastar Pharmaceuticals' (NASDAQ:AMPH) 15% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period
Yahoo FinanceFeb 26 10:51 ET
Amphastar Pharmaceuticals Insiders Sold US$975k Of Shares Suggesting Hesitancy
Simply Wall StFeb 26 08:33 ET
Earnings Preview: AMPH to Report Financial Results Post-market on February 27
Moomoo NewsFeb 21 20:00 ET
Top 2 Health Care Stocks That May Rocket Higher This Month
BenzingaFeb 21 14:17 ET

Comments

Analysts Notebook

Sep 5, 2024 06:06

Columns 'Trump Trade' vs. 'Harris Trade': How They Could Shape Your Portfolio

The 2024 U.S. presidential race between former President Donald Trump and current Vice President Kamala Harris is still "incredibly close," according to the latest New York Times survey. As investors await the outcome of the November election, equity analysts are busy parsing through the candidates' pronouncements for clues on which stocks could benefit from their policies.
Jefferies analysts cited 10 possible policies that Tr...

Trump trade: Bitcoin hit record highs and Tesla hits $1 trillion market cap

31

8

43

Meltyy

May 23, 2024 09:18

$Amphastar Pharmaceuticals (AMPH.US)$ 📣 Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
✨Bioequivalent and therapeutically equivalent to $TEVA ProAir® HFA Inhalation Aerosol
» ANDA approval
» Indication: Tx or prevention of bronchospasm 🫁
» Product launch in Q3 '24

3

Moomoo AI

Jan 19, 2024 13:36

The market's growth expectations seem moderated as EPS growth outpaces average annual share price increase. The recent rise in total shareholder return could suggest business improvement over time.

Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Performs Better Than Its Underlying Earnings Growth Over Last Three Years

Moomoo AI

Dec 20, 2023 05:52

The impressive EPS growth and large insider ownership make Amphastar Pharmaceuticals a potentially attractive investment. The business appears to have reached a growth inflection point.

If EPS Growth Is Important To You, Amphastar Pharmaceuticals (NASDAQ:AMPH) Presents An Opportunity

Explore moomoo's "Insider Activity" for institutional sentiment

Moomoo AI

Nov 18, 2023 06:41

Insider ownership is moderately high, showing company's interest for all shareholders, but the lack of insider buying and significant selling over the last year, casts some doubt on the company's outlook.

This Insider Has Just Sold Shares In Amphastar Pharmaceuticals

AMPH Amphastar Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Trending Stocks